Cerenome
CNSY
21 hedge funds and large institutions have $2.75M invested in Cerenome in 2026 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 11 closing their positions.
85% more capital invested
Capital invested by funds: $1.49M → $2.75M (+$1.26M)
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
3.83% more ownership
Funds ownership: 5.33% → 9.15% (+3.8%)
9% less funds holding
Funds holding: 23 → 21 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$1.13M |
| 2 |
ATPW
Ashton Thomas Private Wealth
Scottsdale,
Arizona
|
+$180K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$140K |
| 4 |
BlackRock
New York
|
+$136K |
| 5 |
VF
Virtu Financial
New York
|
+$83.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$76.2K |
| 2 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
-$52.8K |
| 3 |
Millennium Management
New York
|
-$44.2K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$24.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$23.2K |
CNSY Hedge Fund Activity: Q2 2026 in Review
21 of the 8,339 institutional investors tracked by Wall St. Rank reported a position in Cerenome (CNSY) for Q2 2026, worth a combined $2.75M — up 85% from $1.49M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CNSY and 9 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Capital Management, adding an estimated $1.13M. The largest seller was State Street, exiting entirely with an estimated $76.2K sold.
- 21 institutional investors held Cerenome (CNSY) as of Q2 2026, down from 23 in Q1 2026.
- Funds reported $2.75M of Cerenome stock for Q2 2026, up 85% quarter-over-quarter.
- 9 funds opened new Cerenome positions in Q2 2026 and 11 closed out, a net change of -2 holders.
- The largest Cerenome buyer in Q2 2026 was Vanguard Capital Management, an estimated $1.13M added.
- The largest Cerenome seller in Q2 2026 was State Street, an estimated $76.2K sold.
Based on aggregated 13F filings for Q2 2026.